NYMOX PHARMACEUTICAL CORPORATION Other Gains Losses
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Other Gains Losses of -$716.00 thousand for the 3-month period ending 2024-09-30, per its 6-K filed 2025-01-02.
Financial Statements › Income Statement › Other Income
ifrs-full:OtherGainsLosses · last filed 2025-01-02
- NYMOX PHARMACEUTICAL CORPORATION other gains losses for the quarter ending 2024-09-30 was -$716.00K.
- NYMOX PHARMACEUTICAL CORPORATION other gains losses for the quarter ending 2023-09-30 was -$1.04M.
- NYMOX PHARMACEUTICAL CORPORATION other gains losses for the quarter ending 2023-06-30 was -$1.11M, a 182.84% decline year-over-year.
- NYMOX PHARMACEUTICAL CORPORATION other gains losses for the quarter ending 2023-03-31 was -$1.39M.
| Period end | Other Gains Losses 3 month | Other Gains Losses 6 month | Other Gains Losses 9 month |
|---|---|---|---|
| 2024-09-30 | -$716.00K 6-K · filed 2025-01-02 | -$3.63M 6-K · filed 2025-01-02 | |
| 2023-09-30 | -$1.04M 6-K · filed 2025-01-02 | -$2.15M derived: sum of 2 quarters · filed 2025-01-02 | -$3.53M 6-K · filed 2025-01-02 |
| 2023-06-30 | -$1.11M 6-K · filed 2023-08-14 | -$2.50M 6-K · filed 2023-08-14 | |
| 2023-03-31 | -$1.39M 6-K · filed 2023-05-12 | ||
| 2022-09-30 | -$1.49M 6-K · filed 2023-11-15 | -$151.00K derived: sum of 2 quarters · filed 2023-11-15 | -$5.24M 6-K · filed 2023-11-15 |
| 2022-06-30 | $1.34M 6-K · filed 2023-08-14 | -$3.75M 6-K · filed 2023-08-14 | |
| 2022-03-31 | -$5.09M 6-K · filed 2023-05-12 | ||
| 2021-09-30 | -$3.30M 6-K/A · filed 2022-11-16 | -$7.29M derived: sum of 2 quarters · filed 2022-11-16 | -$9.73M 6-K/A · filed 2022-11-16 |
| 2021-06-30 | -$3.99M 6-K · filed 2022-08-15 | -$6.43M 6-K · filed 2022-08-15 |